Edwards Lifesciences Revenue 2010-2024 | EW

Edwards Lifesciences annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Edwards Lifesciences revenue for the quarter ending March 31, 2024 was $1.598B, a 9.5% increase year-over-year.
  • Edwards Lifesciences revenue for the twelve months ending March 31, 2024 was $6.143B, a 11.68% increase year-over-year.
  • Edwards Lifesciences annual revenue for 2023 was $6.005B, a 11.56% increase from 2022.
  • Edwards Lifesciences annual revenue for 2022 was $5.382B, a 2.86% increase from 2021.
  • Edwards Lifesciences annual revenue for 2021 was $5.233B, a 19.29% increase from 2020.
Edwards Lifesciences Annual Revenue
(Millions of US $)
2023 $6,005
2022 $5,382
2021 $5,233
2020 $4,386
2019 $4,348
2018 $3,723
2017 $3,435
2016 $2,964
2015 $2,494
2014 $2,323
2013 $2,046
2012 $1,900
2011 $1,679
2010 $1,447
2009 $1,321
Edwards Lifesciences Quarterly Revenue
(Millions of US $)
2024-03-31 $1,598
2023-12-31 $1,534
2023-09-30 $1,481
2023-06-30 $1,530
2023-03-31 $1,460
2022-12-31 $1,348
2022-09-30 $1,319
2022-06-30 $1,374
2022-03-31 $1,341
2021-12-31 $1,330
2021-09-30 $1,310
2021-06-30 $1,376
2021-03-31 $1,217
2020-12-31 $1,192
2020-09-30 $1,141
2020-06-30 $925
2020-03-31 $1,129
2019-12-31 $1,174
2019-09-30 $1,094
2019-06-30 $1,087
2019-03-31 $993
2018-12-31 $978
2018-09-30 $907
2018-06-30 $944
2018-03-31 $895
2017-12-31 $889
2017-09-30 $822
2017-06-30 $842
2017-03-31 $884
2016-12-31 $768
2016-09-30 $739
2016-06-30 $759
2016-03-31 $697
2015-12-31 $671
2015-09-30 $616
2015-06-30 $617
2015-03-31 $590
2014-12-31 $618
2014-09-30 $607
2014-06-30 $575
2014-03-31 $522
2013-12-31 $536
2013-09-30 $496
2013-06-30 $517
2013-03-31 $497
2012-12-31 $511
2012-09-30 $448
2012-06-30 $482
2012-03-31 $459
2011-12-31 $430
2011-09-30 $413
2011-06-30 $431
2011-03-31 $405
2010-12-31 $392
2010-09-30 $349
2010-06-30 $365
2010-03-31 $341
2009-12-31 $347
2009-09-30 $326
2009-06-30 $336
2009-03-31 $314
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $54.101B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $226.743B 27.48
Intuitive Surgical (ISRG) United States $141.891B 85.48
DexCom (DXCM) United States $51.973B 78.73
IDEXX Laboratories (IDXX) United States $43.777B 51.31
Alcon (ALC) Switzerland $43.442B 31.13
IQVIA Holdings (IQV) United States $41.922B 24.32
STERIS (STE) Ireland $22.999B 26.88
Waters (WAT) United States $21.000B 30.86
SONOVA HOLDING (SONVY) Switzerland $18.908B 0.00
Hologic (HOLX) United States $17.468B 19.54
Fresenius Medical Care AG KGaA (FMS) Germany $12.869B 15.02
ShockWave Medical (SWAV) United States $12.384B 77.07
Sysmex ADR (SSMXY) Japan $11.134B 34.91
Teleflex (TFX) United States $10.108B 15.73
Globus Medical (GMED) United States $8.970B 26.29
Penumbra (PEN) United States $7.809B 88.74
Masimo (MASI) United States $6.723B 38.73
Glaukos (GKOS) United States $5.504B 0.00
TransMedics (TMDX) United States $4.566B 433.19
Integer Holdings (ITGR) United States $4.029B 24.34
PROCEPT BioRobotics (PRCT) United States $3.533B 0.00
LivaNova (LIVN) United Kingdom $3.318B 19.70
Tandem Diabetes Care (TNDM) United States $3.051B 0.00
Elekta AB (EKTAY) Sweden $2.973B 20.40
Inari Medical (NARI) United States $2.682B 0.00
Nihon Kohden (NHNKY) Japan $2.474B 20.92
RxSight (RXST) United States $2.317B 0.00
Integra LifeSciences Holdings (IART) United States $2.126B 9.27
Veracyte (VCYT) United States $1.705B 0.00
Alphatec Holdings (ATEC) United States $1.543B 0.00
Artivion (AORT) United States $0.993B 95.24
AVANOS MEDICAL, INC (AVNS) United States $0.933B 18.14
OPKO Health (OPK) United States $0.920B 0.00
Silk Road Medical (SILK) United States $0.897B 0.00
OrthoPediatrics (KIDS) United States $0.775B 0.00
Mesa Laboratories (MLAB) United States $0.656B 22.26
Paragon 28 (FNA) United States $0.621B 0.00
SiBone (SIBN) United States $0.593B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.567B 0.00
IRadimed (IRMD) United States $0.555B 31.07
Pacific Biosciences Of California (PACB) United States $0.523B 0.00
Pulse Biosciences (PLSE) United States $0.474B 0.00
Nevro (NVRO) United States $0.386B 0.00
Tactile Systems Technology (TCMD) United States $0.324B 11.10
Treace Medical Concepts (TMCI) United States $0.306B 0.00
Sight Sciences (SGHT) United States $0.282B 0.00
AxoGen (AXGN) United States $0.271B 0.00
908 Devices (MASS) United States $0.236B 0.00
AngioDynamics (ANGO) United States $0.233B 0.00
EDAP TMS S.A (EDAP) France $0.231B 0.00
NeuroPace (NPCE) United States $0.230B 0.00
Delcath Systems (DCTH) United States $0.223B 0.00
Inogen (INGN) United States $0.207B 0.00
Atossa Genetics (ATOS) United States $0.201B 0.00
Alpha Tau Medical (DRTS) Israel $0.189B 0.00
CVRx (CVRX) United States $0.179B 0.00
ClearPoint Neuro (CLPT) United States $0.168B 0.00
Semler Scientific (SMLR) United States $0.166B 8.42
Accuray (ARAY) United States $0.159B 0.00
Spectral Diagnostics (EDTXF) Canada $0.108B 0.00
Sensus Healthcare (SRTS) United States $0.103B 21.59
KORU Medical Systems (KRMD) United States $0.101B 0.00
Yubo Biotech (YBGJ) China $0.091B 0.00
Neuronetics (STIM) United States $0.076B 0.00
EnVVeno Medical (NVNO) United States $0.067B 0.00
Hyperfine (HYPR) United States $0.065B 0.00
Envoy Medical (COCH) United States $0.064B 0.00
Monogram Orthopaedics (MGRM) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.057B 0.00
Vicarious Surgical (RBOT) United States $0.056B 0.00
SEP Acquisition (SEPA) United States $0.054B 0.00
DarioHealth (DRIO) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.048B 0.00
LENSAR (LNSR) United States $0.046B 0.00
Autonomix Medical (AMIX) United States $0.043B 0.00
ReWalk Robotics (LFWD) Israel $0.043B 0.00
Precision Optics (POCI) United States $0.040B 0.00
Pixie Dust Technologies (PXDT) Japan $0.036B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
T2 Biosystems (TTOO) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.032B 0.00
Aspira Women's Health (AWH) United States $0.032B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
Accelerate Diagnostics (AXDX) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
PAVmed (PAVM) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
NexGel (NXGL) United States $0.014B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Avinger (AVGR) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00